The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 Feb 2023 17:00

RNS Number : 2148P
Mobeus Income & Growth 2 VCT PLC
07 February 2023
 

MOBEUS INCOME & GROWTH 2 VCT PLC

("the Company")

LEI: 213800LY62XLI1B4VX35

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2022

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 31 December 2022. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 December 2022

(unaudited)

At 30 September 2022

(unaudited)

Net assets attributable to shareholders

£70,433,343

£68,459,466

Shares in issue

89,496,349

80,022,131

Net asset value (NAV) per share

78.70 pence

85.55 pence

Cumulative dividends paid

140.00 pence

134.00 pence

Cumulative Total return (net asset value basis) per share since inception

218.70 pence

219.55 pence

NAV total return per share, after adding back the dividend of 6.00 pence per share paid in November 2022, has decreased by 1.0% in the quarter ended 31 December 2022. However, the NAV per share has decreased by 6.85 pence in the quarter (an 8.0% decrease).

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

Partial realisation during the period

On 24 November 2022, the Company sold its equity investment in EOTH Limited. The Company received £4.33 million in cash from the sale (including accrued preference dividends). Total proceeds received to date over the seven and a half year life of the investment were £5.64 million compared to an original investment cost of £0.82 million, a multiple on cost of 6.9x and an IRR of 23.2%.

 

Loan repayment during the period

On 21 October 2022, the Company received a loan repayment of £0.37 million from Jablite Holdings Limited.

 

DIVIDEND PAID DURING THE PERIOD

On 7 November 2022, an interim dividend of 6.00 pence per share in respect of the year ending 31 March 2023 was paid to all Shareholders whose names were on the register on 30 September 2022.

 

FUNDRAISING

 

On 5 October 2022 the Company launched an Offer for Subscription of £16 million (including over-allotment amount), alongside Offers from the other Mobeus VCTs. The Company received subscriptions amounting to the full amount within the quarter and was subsequently then closed to further applications. In accordance with the Offers' prospectus, in respect of the initial amount, an allotment of 9,693,230 Ordinary shares took place on 16 November 2022 raising net funds (after costs) of £7.71 million for the Company. In respect of the over-allotment amounts, a second allotment of 9,782,440 Ordinary shares took place on 6 February 2023 raising net funds (after costs) of £7.70 million for the Company.

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary

020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQDLFBXLLZBBB
Date   Source Headline
26th Jan 20213:00 pmRNSReplacement - Transaction in Own Shares
11th Jan 202112:00 pmRNSRealisation of Investment
17th Dec 202011:40 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20203:23 pmRNSInterim Report
29th Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20203:58 pmRNSIMPACT OF RECENT DISPOSALS UPON NET ASSET VALUE
9th Sep 202011:05 amRNSAGM Results
8th Sep 20203:30 pmRNSInterim Management Statement to 30 June 2020
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
10th Aug 20208:54 amRNSRevised AGM Arrangements
3rd Jul 20204:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20207:00 amRNSAnnual Financial Report
14th May 20209:15 amRNSDividend Declaration
2nd Apr 20205:10 pmRNSIssue of Equity
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
23rd Mar 202011:30 amRNSTransaction in Own Shares
2nd Mar 202010:23 amRNSInterim Management Statement to 31 December 2019
28th Feb 20201:09 pmRNSFundraising Update
26th Feb 20202:48 pmRNSInterim Dividend
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
6th Feb 20203:45 pmRNSOffer Increase
3rd Feb 202011:30 amRNSTotal Voting Rights
13th Jan 202011:00 amRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20193:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
12th Dec 201912:40 pmRNSTransaction in Own Shares
28th Nov 201910:15 amRNSHalf-Year Report for the six months ended 30/09/19
20th Nov 20191:00 pmRNSHalf-year Report
5th Nov 20194:00 pmRNSReduction of Capital
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
11th Sep 201912:41 pmRNSResult of AGM
10th Sep 20195:00 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.